TITLE

UBICHEM APPROVED FOR CGMP RADIOLABELLED API PRODUCTION

PUB. DATE
July 2010
SOURCE
Worldwide Biotech;Jul2010, Vol. 22 Issue 7, p8
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article that following the completion of a regulatory inspection of Ubichem UK in July 2010, the company has been approved for the supply of cyclic guanosine monophosphate (cGMP) radiolabelled active pharmaceutical ingredients (API). According to managing director of Ubichem Research Jozsef Repasi, the approval allows the company to supply radiolabelled materials for use in human clinical trials.
ACCESSION #
51861713

 

Related Articles

  • In-vivo imaging characteristics of two fluorinated flumazenil radiotracers in the rat. Dedeurwaerdere, Stefanie; Gregoire, Marie-Claude; Vivash, Lucy; Roselt, Peter; Binns, David; Fookes, Christopher; Greguric, Ivan; Pham, Tien; Loc’h, Christian; Katsifis, Andrew; Hicks, Rodney; O’Brien, Terence; Myers, Damian // European Journal of Nuclear Medicine & Molecular Imaging;Jun2009, Vol. 36 Issue 6, p958 

    [11C]Flumazenil shows promise as a clinical and research PET radiotracer to image changes in GABAA central benzodiazepine receptor (cBZR), but its widespread use has been limited by practical limitations of [11C]. This study evaluated the imaging characteristics of two fluorinated PET...

  • Do we need randomised trials to evaluate diagnostic procedures? Valk, Peter E. // European Journal of Nuclear Medicine & Molecular Imaging;2004, Vol. 31 Issue 1, p132 

    Focuses on the need for randomized controlled trial in nuclear medicine to evaluate diagnostic procedures. Benefits from randomized controlled trials.

  • Polydimethylsiloxane: An Innovation in Radioguided Surgery. Vitral, Geraldo S. F.; Bastos, Ronaldo R.; Raposo, Nádia R. B . // Journal of Surgical Radiology;Oct2012, Vol. 3 Issue 4, p198 

    Introduction The certification of correct positioning of radiotracers in relationship to suspected lesions of the breast in radioguided occult lesion localization (ROLL), is a well-known problem. The objective of this study was the clinical evaluation of an innovative technical step in ROLL,...

  • PET imaging with 11C-acetate in prostate cancer: a biochemical, radiochemical and clinical perspective. Soloviev, Dmitri; Fini, Alberto; Chierichetti, Franca; Al-Nahhas, Adil; Rubello, Domenico // European Journal of Nuclear Medicine & Molecular Imaging;May2008, Vol. 35 Issue 5, p942 

    In the present study, the potential clinical role of 11C-acetate PET mainly in the differential diagnosis, in the staging and in the follow-up of prostate cancer patients is reported. Each of the above points has been accurately investigated by studying the specific biochemical and...

  • Degradation of myocardial perfusion SPECT images caused by contaminants in thallous (201Tl) chloride. Staelens, Steven G.; de Wit, Tim C.; Lemahieu, Ignace A.; Beekman, Freek J. // European Journal of Nuclear Medicine & Molecular Imaging;May2008, Vol. 35 Issue 5, p922 

    Thallous (201Tl) chloride is a single-photon emission computed tomography (SPECT) tracer mainly used for assessing perfusion and viability of myocardial tissue. 201Tl emits X-rays around 72 keV and gammas at 167 keV, and has a half-life of 73 h. Regulations allow an intrinsic contamination up to...

  • Absolute quantitation of myocardial blood flow with 201Tl and dynamic SPECT in canine: optimisation and validation of kinetic modelling. Iida, Hidehiro; Eberl, Stefan; Kyeong-Min Kim; Tamura, Yoshikazu; Ono, Yukihiko; Nakazawa, Mayumi; Sohlberg, Antti; Zeniya, Tsutomu; Hayashi, Takuya; Watabe, Hiroshi // European Journal of Nuclear Medicine & Molecular Imaging;May2008, Vol. 35 Issue 5, p896 

    201Tl has been extensively used for myocardial perfusion and viability assessment. Unlike 99mTc-labelled agents, such as 99mTc-sestamibi and 99mTc-tetrofosmine, the regional concentration of 201Tl varies with time. This study is intended to validate a kinetic modelling approach for in vivo...

  • Development of new folate-based PET radiotracers: preclinical evaluation of Ga-DOTA-folate conjugates. Fani, Melpomeni; Wang, Xuejuan; Nicolas, Guillaume; Medina, Christelle; Raynal, Isabelle; Port, Marc; Maecke, Helmut // European Journal of Nuclear Medicine & Molecular Imaging;Jan2011, Vol. 38 Issue 1, p108 

    Purpose: A number of In- and Tc-folate-based tracers have been evaluated as diagnostic agents for imaging folate receptor (FR)-positive tumours. A Ga-folate-based radiopharmaceutical would be of great interest, combining the advantages of PET technology and the availability of Ga from a...

  • Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trials. Aboagye, Eric; Gilbert, Fiona; Fleming, Ian; Beer, Ambros; Cunningham, Vincent; Marsden, Paul; Visvikis, Dimitris; Gee, Antony; Groves, Ashley; Kenny, Laura; Cook, Gary; Kinahan, Paul; Myers, Melvyn; Clarke, Larry // European Radiology;Jul2012, Vol. 22 Issue 7, p1465 

    The evaluation of drug pharmacodynamics and early tumour response are integral to current clinical trials of novel cancer therapeutics to explain or predict long term clinical benefit or to confirm dose selection. Tumour vascularity assessment by positron emission tomography could be viewed as a...

  • 99mTcO(MAG2-3G3-dimer): a new integrin αvβ3-targeted SPECT radiotracer with high tumor uptake and favorable pharmacokinetics. Jiyun Shi; Lijun Wang; Young-Seung Kim; Shizhen Zhai; Bing Jia; Fan Wang; Shuang Liu // European Journal of Nuclear Medicine & Molecular Imaging;Nov2009, Vol. 36 Issue 11, p1874 

    This report presents the synthesis of a cyclic RGD dimer conjugate, MAG2-G3-E[G3-c(RGDfK)]2 (MAG2-3G3-dimer, G3 = Gly-Gly-Gly, MAG2 = S-benzoyl mercaptoacetylglycylglycyl), and evaluation of its 99mTc complex, 99mTcO(MAG2-3G3-dimer), as a new radiotracer for imaging the tumor integrin αvβ3...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics